Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

State-level burden of early onset colorectal cancer in the US: a Global Burden of Disease study, 1980 to 2021.

Proceedings (Baylor University. Medical Center)·2026
Same author

P066 Real-World Experience of Ustekinumab in Crohn's Disease Patients With Prior Anti-TNF Therapy at a Tertiary Care Hospital.

The American journal of gastroenterology·2023
Same author

Topical hemostatic agents for malignancy-related GI bleeding: Is it time to prioritize their use?

Gastrointestinal endoscopy·2022
Same author

ERCP in the evaluation of biliary strictures: Tissue is the issue! Is FISH the answer?

Gastrointestinal endoscopy·2022
Same author

Red dichromatic imaging in acute GI bleeding: Does it make a difference?

Gastrointestinal endoscopy·2022
Same author

Cost-effectiveness analysis of infected necrotizing pancreatitis management in an academic setting.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2021

Related Experiment Videos

Mirizzi syndrome.

Sushil K Ahlawat, Rohit Singhania, Firas H Al-Kawas

    Current Treatment Options in Gastroenterology
    |March 30, 2007
    PubMed
    Summary

    Mirizzi syndrome, a complication of gallstones, requires prompt diagnosis and surgical management. Imaging like ERCP is key for diagnosis, while open surgery remains the standard treatment for this condition.

    Area of Science:

    • Gastroenterology
    • Surgical Oncology
    • Diagnostic Imaging

    Background:

    • Mirizzi syndrome is a significant complication of gallstone disease, often presenting diagnostic challenges.
    • Delayed or missed diagnosis can lead to increased patient morbidity and mortality.

    Purpose of the Study:

    • To review the diagnostic modalities and current management strategies for Mirizzi syndrome.
    • To highlight the importance of accurate preoperative diagnosis for optimal patient outcomes.

    Main Methods:

    • Review of imaging techniques including ultrasonography (US), CT, magnetic resonance cholangiopancreatography (MRCP), and endoscopic retrograde cholangiopancreatography (ERCP).
    • Discussion of surgical (open and laparoscopic) and endoscopic treatment options.
    • Analysis of diagnostic accuracy and therapeutic efficacy of different modalities.

    Related Experiment Videos

    Main Results:

    • US, CT, and MRCP aid in preoperative diagnosis, with ERCP considered the gold standard for delineating obstruction and potential fistulas.
    • Open surgery is the established standard treatment for Mirizzi syndrome, offering good outcomes.
    • Laparoscopic approaches are often contraindicated due to higher risks, while endoscopic treatments serve as alternatives for high-risk patients or as a temporizing measure.

    Conclusions:

    • Accurate preoperative diagnosis of Mirizzi syndrome is crucial for effective management.
    • Open surgical intervention remains the primary treatment, with endoscopic procedures offering valuable alternatives in select cases.